SE7608174L - Forfarande for framstellning av antiserum - Google Patents

Forfarande for framstellning av antiserum

Info

Publication number
SE7608174L
SE7608174L SE7608174A SE7608174A SE7608174L SE 7608174 L SE7608174 L SE 7608174L SE 7608174 A SE7608174 A SE 7608174A SE 7608174 A SE7608174 A SE 7608174A SE 7608174 L SE7608174 L SE 7608174L
Authority
SE
Sweden
Prior art keywords
antiserum
animal
plasma
procedure
serum
Prior art date
Application number
SE7608174A
Other languages
English (en)
Swedish (sv)
Inventor
W Stephan
R Kotitschke
Original Assignee
Biotest Serum Institut Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotest Serum Institut Gmbh filed Critical Biotest Serum Institut Gmbh
Publication of SE7608174L publication Critical patent/SE7608174L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE7608174A 1975-07-18 1976-07-16 Forfarande for framstellning av antiserum SE7608174L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2532151A DE2532151C3 (de) 1975-07-18 1975-07-18 Antisenim zur quantitativen Bestimmung der Abbauprodukte des Fibrins und Fibrinogen« und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
SE7608174L true SE7608174L (sv) 1977-01-19

Family

ID=5951831

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7608174A SE7608174L (sv) 1975-07-18 1976-07-16 Forfarande for framstellning av antiserum

Country Status (9)

Country Link
US (1) US4147765A (de)
JP (1) JPS5212922A (de)
AT (1) AT349155B (de)
CH (1) CH620299A5 (de)
DE (1) DE2532151C3 (de)
FR (1) FR2318423A1 (de)
GB (1) GB1527268A (de)
NL (1) NL7607289A (de)
SE (1) SE7608174L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59192285U (ja) * 1983-06-08 1984-12-20 栗原　信雄 表示灯付きコ−ド接続具
JPS59192922U (ja) * 1983-06-09 1984-12-21 横浜ゴム株式会社 空気式防「げん」材
DE3400434A1 (de) * 1984-01-09 1985-09-26 Behringwerke Ag, 3550 Marburg Bestimmung von fibrin mit fibrin-spezifischen antikoerpern
US5357042A (en) * 1984-04-23 1994-10-18 The General Hospital Corporation Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
US4927916A (en) * 1984-04-23 1990-05-22 The General Hospital Corporation Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides
FR2565984B1 (fr) * 1984-06-19 1986-08-29 Rhone Poulenc Sante Nouvelles substances biologiquement actives, leur procede de preparation a partir du fibrinogene bovin et les compositions qui les contiennent
US5116613A (en) * 1985-01-08 1992-05-26 The General Hospital Corporation Antibody-thrombolytic agent product and method of use
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
WO1988001514A1 (en) * 1986-08-25 1988-03-10 American Biogenetic Sciences, Inc. Monoclonal antibodies to fibrin
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5453359A (en) 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
US6114506A (en) * 1996-09-20 2000-09-05 General Hospital Corporation Composition and method for enhancing fibrinolysis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1362776A (en) * 1970-07-17 1974-08-07 Wellcome Found Immunological reagent

Also Published As

Publication number Publication date
AT349155B (de) 1979-03-26
DE2532151A1 (de) 1977-01-20
NL7607289A (nl) 1977-01-20
GB1527268A (en) 1978-10-04
FR2318423B1 (de) 1981-08-07
JPS5654586B2 (de) 1981-12-26
DE2532151B2 (de) 1977-05-12
US4147765A (en) 1979-04-03
CH620299A5 (de) 1980-11-14
FR2318423A1 (fr) 1977-02-11
JPS5212922A (en) 1977-01-31
DE2532151C3 (de) 1979-06-13
ATA488376A (de) 1978-08-15

Similar Documents

Publication Publication Date Title
SE7608174L (sv) Forfarande for framstellning av antiserum
FI851635A0 (fi) Antikroppkompositioner av terapeutiska aemnen vilka har foerlaengd halveringstid i blodserumet.
CH371261A (de) Verfahren zur Herstellung von linearen, ungesättigten Copolymeren mit hohem Molekulargewicht
ES2039709T3 (es) Un procedimiento para preparar una composicion anticoagulante.
DE69020708D1 (de) Verfahren zur Herstellung von biMOS-Halbleiterbauelementen mit verbesserter Schnelligkeit und Zuverlässigkeit.
DE68918217D1 (de) Familie von modifizierten Antikörpern mit hoher Affinität zur Behandlung von Krebs.
NO153142C (no) Fremgangsmaate for fremstilling av kopolymerisater av etylen og c3-c6-alfa-olefiner.
CH385211A (de) Verfahren zur Herstellung von am Iminostickstoff substituierten 2-Imino-1,3-di-N-heterocyclen
ES2058343T3 (es) Piridinas disubstituidas.
ES535409A0 (es) Procedimiento para pasterizar un plasma de radical-humano
CH555793A (de) Verfahren zur herstellung von gegebenenfalls substituierten perfluoralkyljodid-olefin- bzw.-cycloolefin-1:1-addukten.
NO147189C (no) Fremgangsmaate for immobilisering av oksido-reduktanseenzymer i en filamentstruktur
NO143395C (no) Fremgangsmaate for fremstilling av proteinfilamenter
SE7603837L (sv) Parenteral losning
AT333019B (de) Verfahren und anordnung zur herstellung von holzspanplatten
ATE115188T1 (de) Antikörper gegen fibrin, immunogen zur herstellung desselben, verfahren zur bestimmung von fibrin und pharmazeutisches präparat auf basis der antikörper.
SU605608A1 (ru) Способ исследовани ветвей магистральных кровеносных сосудов
SU533453A2 (ru) Способ точени внутренних поверхностей
BE587068A (fr) Dérivés du yohimbane de la série naturelle ou synthétique et procédé de préparation
ES268958A1 (es) Procedimiento para la obtenciën de vacunas
SU572590A1 (ru) Струйный усилитель
GB1013192A (en) Diagnostic reagent composition for use in determining blood coagulation factors
ES331307A1 (es) Procedimiento de preparacion de hidrolizados de proteinas.
CH434759A (de) Verfahren zur Herstellung von vulkanisierbaren, grösstenteils linearen, hochmolekularen Copolymeren
ES384051A1 (es) Procedimiento industrial de obtencion y concentracion de inmunoglobulinas a partir de suero o plasma humanos y de origen animal.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7608174-4